Default: ChemMedChem

ISSN: 1860-7179

Journal Home

Journal Guideline

ChemMedChem Q1 Unclaimed

John Wiley and Sons Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

ChemMedChem is a journal indexed in SJR in Biochemistry and Drug Discovery with an H index of 119. It has a price of 2040 €. It has an SJR impact factor of 0,761 and it has a best quartile of Q1. It has an SJR impact factor of 0,761.

ChemMedChem focuses its scope in these topics and keywords: inhibitors, drug, human, activity, analogues, chemistry, chemmedchem, acid, ligands, medicinal, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Metrics

ChemMedChem

0,761

SJR Impact factor

119

H Index

211

Total Docs (Last Year)

854

Total Docs (3 years)

11840

Total Refs

3091

Total Cites (3 years)

842

Citable Docs (3 years)

3.65

Cites/Doc (2 years)

56.11

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


inhibitors, drug, human, activity, analogues, chemistry, chemmedchem, acid, ligands, medicinal, molecules, synthesis, cover, complexes, experimental, proteinprotein, potency, dual, hiv, identification, inhibit, interactions, oxygen, p, platinum, reactive,



Best articles by citations

Synthesis, Characterization, and Antileukemic Properties of Naphthoquinone Derivatives of Lawsone

View more

Integrated Synthetic, Pharmacological, and Computational Investigation of cis-2-(3,5-Dichlorophenylcarbamoyl)cyclohexanecarboxylic Acid Enantiomers As Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 4

View more

Synthesis and Evaluation of Indatraline-Based Inhibitors for Trypanothione Reductase

View more

Modified 5'-Trityl Nucleosides as Inhibitors ofPlasmodium falciparumdUTPase

View more

Inside Cover: Design, Synthesis, and Biological Evaluation of the First Podophyllotoxin Analogues as Potential Vascular-Disrupting Agents (ChemMedChem 12/2010)

View more

Fragment-Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus 1

View more

Cover Picture: Molecular Assembly of Multifunctional 99mTc Radiopharmaceuticals Using "Clickable" Amino Acid Derivatives (ChemMedChem 12/2010)

View more

Symmetry Complementarity-Guided Design of Anthrax Toxin Inhibitors Based on beta-Cyclodextrin: Synthesis and Relative Activities of Face-Selective Functionalized Polycationic Clusters

View more

Protein Kinases as Drug Targets. Edited by Bert Klebl, Gerhard Muller and Michael Hamacher.

View more

Allosteric Inhibitor Development Targeting HIV-1 Integrase

View more

Conjugation of ATIII-Binding Pentasaccharides to Extend the Half-Life of Proteins: Long-Acting Insulin

View more

G-Quadruplex Recognition by Quinacridines: a SAR, NMR, and Biological Study

View more
SHOW MORE ARTICLES

Design and Synthesis of 4-(2,4,5-Trifluorophenyl)butane-1,3-diamines as Dipeptidyl Peptidase IV Inhibitors

View more

Vitamin B12 as a Carrier for the Oral Delivery of Insulin

View more

Development of 2,3,5-Triaryl-1H-pyrroles as Estrogen Receptor a Selective Ligands

View more

Design and Synthesis of N-Acylated Aza-Goniothalamin Derivatives and Evaluation of Their in vitro and in vivo Antitumor Activity

View more

Structure-Activity Relationship of Trifluoromethyl-Containing Metallocenes: Electrochemistry, Lipophilicity, Cytotoxicity, and ROS Production

View more

Structure-Activity Relationship Refinement and Further Assessment of Indole-3-glyoxylamides as a Lead Series against Prion Disease

View more

SpiroZin1: A Reversible and pH-Insensitive, Reaction-Based, Red-Fluorescent Probe for Imaging Biological Mobile Zinc

View more

Second-Generation Iminoxylitol-Based Pharmacological Chaperones for the Treatment of Gaucher Disease

View more

Design and Synthesis of Novel Cyclooxygenase-1 Inhibitors as Analgesics: 5-Amino-2-ethoxy-N-(substituted-phenyl)benzamides

View more

Predicting Lipophilicity of Drug-Discovery Molecules using Gaussian Process Models

View more

Tritium-Labeled Brivaracetam with High Specific Activity: Preparation, Characterization and Application in Human Brain Samples

View more

FAQS